论文部分内容阅读
经体内动物实验研究表明,中药复方天仙胶囊对小鼠移植性肿瘤生长有明显的抑制作用。并可减少癌细胞的血行转移和淋巴转移。临床近期对48例ⅢⅣ期食管癌和胃癌患者的治疗结果,好转率为2.1％,瘤体稳定率为83.3％,该药可减轻癌性疼痛和吞咽困难等症状。患者巨噬细胞吞噬率和吞噬指数有所提高。临床和实验結果均表明复方天仙胶囊对造血系统和心肝肾等重要脏器无明显毒副作用,仅部分患者出现灼心等轻度消化道反应。
The in vivo animal experiments showed that the traditional Chinese compound compound Tianxian capsule has obvious inhibitory effect on transplanted tumor growth in mice. And can reduce the blood cell metastasis and lymphatic metastasis. In the recent clinical treatment of 48 patients with stage III IV esophageal cancer and gastric cancer, the improvement rate was 2.1%, and the tumor body stability rate was 83.3%. The drug can relieve symptoms such as cancer pain and dysphagia. Patients’ macrophage phagocytosis rate and phagocytic index increased. Both clinical and experimental results showed that Compound Tianxian Capsule had no obvious toxic side effects on hematopoietic system and heart, liver, kidney and other important organs, and only some patients had a slight gastrointestinal reaction such as burning heart.